5248242026-08-265248242026-08-262026-08-26RelatedPartyTransactionDomain15248242026-08-262026-08-26ResolutionOrAgendaDomain15248242026-08-26ResolutionOrAgendaDomain15248242026-08-262026-08-26ResolutionOrAgendaDomain25248242026-08-26ResolutionOrAgendaDomain25248242026-08-262026-08-26ResolutionOrAgendaDomain35248242026-08-26ResolutionOrAgendaDomain35248242026-08-262026-08-26ResolutionOrAgendaDomain45248242026-08-26ResolutionOrAgendaDomain45248242026-08-262026-08-26ResolutionOrAgendaDomain55248242026-08-26ResolutionOrAgendaDomain55248242026-08-262026-08-26ResolutionOrAgendaDomain65248242026-08-26ResolutionOrAgendaDomain65248242026-08-262026-08-26ResolutionOrAgendaDomain75248242026-08-26ResolutionOrAgendaDomain7iso4217:INRxbrli:pureBAL PHARMA LIMITEDBALPHARMANew2026-09-2411:30:002026-08-26Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)39th Annual General MeetingThursday2026-09-2411:30:00Video Conference (VC) or Other Audio-Visual Means (OAVM)7Bal Pharma LimitedDesa Marketing InternationalDesa Marketing International is the Proprietary concern of Mr. Shailesh Siroya, Managing Director of Bal Pharma LimitedAny other transactionThe Company has been availing the services of Messrs. Desa Marketing International for vendor identification and development; , marketing and promotion of the Company's pharmaceutical products in India and overseas; , facilitating export business; and and providing market intelligence and business development support3000000002026-05-202029-05-19Aggregate value of transactions shall not exceeds ₹30 Crore in one financial year during the tenure of the agreement.Ordinary ResolutionAdoption of Financial StatementsTo receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, the Statement of Profit and Loss for the financial year ended as on that date and the Cash Flow Statement together with the Reports of the Board of Directors and the Auditors thereon.Ordinary ResolutionIssuance/Corporate ActionDividendDeclare dividend of Rs. 1.20 per Equity Share of Rs 10/- each.Ordinary ResolutionOthersOthersDirectors Retire by RotationRe-appoint Mr. Ravindra Kumar Kothari, (DIN : 03418320), who retires by rotation, as a Director of the CompanyOrdinary ResolutionOthersOthersRatify the remuneration payable to Cost Auditors for the Financial Year 2026-27Ratify the remuneration payable to Cost Auditors for the Financial Year 2026-27Ordinary ResolutionRelated Party TransactionRenew contract with Messrs. Desa Marketing InternationalSpecial ResolutionOthersOthersChange of DesignationChange in designation of Mr. Ravindra Kumar Kothari (DIN – 03418320) from Non-Executive Director to Whole-Time DirectorSpecial ResolutionOthersOthersChange of DesignationChange in designation of Mr. Virupakshaya Himesh (DIN: 08554422) from Whole-Time Director to Non-Executive Director.